JUMP TO A TOPIC
![]()
More About Mesothelioma Treatment at MD Anderson Cancer Center
Mesothelioma is a rare and aggressive disease. Not many doctors have the training or experience to treat it effectively, which provides a challenge for patients and their families.
MD Anderson Cancer Center, located in Houston, Texas, is one of the world’s top mesothelioma cancer centers and patients often travel across the country for care. MD Anderson has the honor of being a National Cancer Institute-designated center. It is one of just a few in the state of Texas with this recognition.
Mesothelioma treatment provided at MD Anderson includes surgery and therapies on a case-by-case basis. This allows medical staff to provide a treatment plan for the unique needs of the individual patient.
Dr. Anne Tsao is the Director of the hospital’s Mesothelioma Program. Dr. Kanwal Raghay is the medical oncologist for peritoneal mesothelioma cases.
MD Anderson Cancer Center features a Thoracic Center, which houses treatment for pleural mesothelioma. MD Anderson also sees peritoneal mesothelioma cases.
There are four locations seeing people with mesothelioma:
- MD Anderson League City
- MD Anderson Sugar Land
- MD Anderson Woodlands
- MD Anderson West Houston
Experienced Mesothelioma Specialists
- Dr. Anne Tsao, Director of Mesothelioma Program
- Dr. Kanwal Raghay, gastrointestinal medical oncologist
Affiliations
- University of Texas
Treatment Specialties
- Extrapleural pneumonectomy surgery (pleural mesothelioma)
- Pleurectomy/decortication surgery (pleural mesothelioma)
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Targeted therapy, such as oncolytic virus therapy
Get Connected to MD Anderson Cancer Center
MD Anderson Cancer Center is a home to more than a dozen clinical studies involving mesothelioma. Dr. Anne Tsao is the Director of Mesothelioma at the hospital and leads a team of specialists offering surgery, chemotherapy, immunotherapy and more.
Why Choose MD Anderson?
- Ranked first in cancer treatment among all hospitals
- Offering a variety of therapy options for patients
- Highly skilled staff includes surgeons and oncologists
What Mesothelioma Care Is Like at MD Anderson
MD Anderson Cancer Center is ranked as the top hospital in America in 2024-2025 for cancer treatment. This is a testament to the quality of care patients experience and comfort they feel throughout the process.
Cancer care is not limited just to the medicines provided or surgeries performed. MD Anderson excels at easing the anxieties of cancer patients and their families. There are various housing programs used by the cancer center to help out-of-town traveling families regain a sense of normalcy through the challenging period.
MD Anderson also offers mental health services to improve patient quality of life before, during and after mesothelioma treatment.
For the fifth straight year, in 2025-2026, the U.S. News & World Report Best Hospitals Honor Roll ranked MD Anderson Cancer Center the No. 1 hospital in America for cancer treatment. This is a prestigious honor and evidence of the mesothelioma cancer center’s high-quality care for patients.
Hospital Ranking
- Not ranked in the U.S. News & World Report 2025-2026 Hospitals Honor Roll
- Ranked 1st in cancer treatment
- Ranked 13th in gastrointestinal cancer surgery (peritoneal mesothelioma)
- High performing for lung cancer surgery (pleural mesothelioma)
Host Site for Mesothelioma Clinical Trials
MD Anderson Cancer Center is a regular Uhost site for mesothelioma clinical trials. One of the most prominent trials was the DREAM3R study featuring the immunotherapy drug durvalumab. The trial uses the immune checkpoint inhibitor with chemotherapy.
The trial is one of the recruiting studies at MD Anderson. There are a total of 16 clinical trials featuring malignant mesothelioma. One of them uses pleurectomy/decortication surgery after neoadjuvant chemotherapy and intensity-modulated radiation therapy.
MD Anderson hosted a phase 2 immunotherapy clinical trial for peritoneal mesothelioma. Doctors gave patients atezolizumab and bevacizumab, which achieved a 40% response rate. Patient survival before disease progression was also nearly 18 months, much better than systemic chemotherapy.
How to Begin Treatment at MD Anderson
MD Anderson Cancer Center is located in a major metropolitan city, which grants access to patients traveling by plane from hours away. The hospital welcomes patients from other states – or patients in far-away parts of Texas.
Connecting with MD Anderson is much easier with the help of a patient advocate. Nurse Karen Ritter is the best and most compassionate patient guide for mesothelioma patients. Her number one goal is to help connect people with the medical resources they need to improve their prognosis.
Email Nurse Karen at karen@mesotheliomaguide.com or request a list of cancer center recommendations based on your location, disease and other specific criteria.
Sources & Author
- Mesothelioma. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/cancer-types/mesothelioma.html. Accessed: 02/22/2022.
- University of Texas MD Anderson Cancer Center. U.S. News & World Report. Retrieved from: https://health.usnews.com/best-hospitals/area/tx/university-of-texas-md-anderson-cancer-center-6741945. Accessed: 08/11/2025.
- Mesothelioma Treatment. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/cancer-types/mesothelioma/mesothelioma-treatment.html. Accessed: 02/22/2022.
- Find a Cancer Center. National Cancer Institute. Retrieved from: https://www.cancer.gov/research/infrastructure/cancer-centers/find. Accessed: 03/03/2022.
- Atezolizumab and bevacizumab show meaningful responses for malignant peritoneal mesothelioma patients. MD Anderson Cancer Center. Retrieved from: https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html. Accessed: 02/22/2022.
- DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma (DREAM3R). Clinicaltrials.gov. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04334759. Accessed: 03/02/2022.
AI Summary of MD Anderson Cancer Center
MD Anderson Cancer Center, located in Houston, Texas, is internationally recognized as a leading facility for cancer treatment, including mesothelioma. As part of the University of Texas system, it brings together some of the most skilled specialists and researchers dedicated to fighting this rare and aggressive disease. Many patients travel from around the world to seek care here because of the center's reputation for excellence and comprehensive treatment options. The center offers a range of therapies tailored to each patient's specific situation, including surgery, chemotherapy, immunotherapy, radiation therapy, and targeted treatments, with a focus on personalized care.
The hospital's Mesothelioma Program is led by Dr. Anne Tsao, who is a renowned expert in the field. She oversees a team of specialists who collaborate to provide the latest and most effective treatment strategies. The center treats both pleural mesothelioma, which affects the lining of the lungs, and peritoneal mesothelioma, which involves the abdominal lining. Patients can access various clinical trials at MD Anderson, testing new therapies and treatment combinations that may improve outcomes and quality of life. Their dedicated Thoracic Center provides specialized care for pleural mesothelioma patients, ensuring that each individual receives treatment suited to their condition.
MD Anderson is committed to not only delivering top-tier medical treatments but also supporting the emotional and practical needs of patients and their families. The hospital offers programs to ease travel and accommodation challenges, as well as mental health services to promote overall well-being during treatment. Recognized as the top hospital in the country for cancer care, MD Anderson’s multidisciplinary approach and cutting-edge research make it a beacon of hope for those facing mesothelioma. Patients seeking treatment can benefit from the expertise of the hospital’s highly trained staff and advanced clinical trials, giving them access to the most promising therapies available today.